Jin Medical International Ltd. (ZJYL)

Jin Medical International Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Revenue	20.69	23.5	19.82	19.19	20.76
Revenue Growth (YoY)	-11.98%	18.57%	3.29%	-7.58%	28.22%
Cost of Revenue	14.64	14	13.04	-12.99	-14.4
Gross Profit	6.04	9.5	6.78	6.2	6.36
Selling, General & Admin	-3.88	-4.37	-2.37	2.18	2.16
Research & Development	-1.56	-1.5	-1.54	1.89	1.57
Total Operating Expenses	-5.44	-5.86	-3.92	4.07	3.73
Operating Income	0.61	3.64	2.87	2.13	2.63
Interest Income	0.79	0.47	0.18	0.18	-0.01
Other Non-Operating Income (Expense)	0.2	0.08	0.17	0.43	0.26
Total Non-Operating Income (Expense)	0.99	0.54	0.35	0.61	0.25
Pretax Income	1.6	4.18	3.22	2.74	2.88
Provision for Income Taxes	-0.21	-0.76	-0.34	0.04	0.25
Net Income	1.19	3.68	2.88	2.71	2.63
Minority Interest in Earnings	0.19	-0.26	-	-	-
Net Income to Common	1.19	3.68	2.88	2.71	2.63
Net Income Growth	-67.59%	27.71%	6.34%	2.84%	19.30%
Shares Outstanding (Basic)	8	8	7	7	7
Shares Outstanding (Diluted)	8	8	7	7	7
Shares Change (YoY)	0.05%	7.81%	7.51%	-	-
EPS (Basic)	0.20	0.40	0.40	0.40	0.40
EPS (Diluted)	0.20	0.40	0.40	0.40	0.40
EPS Growth	-50.00%	-	-	-	21.21%
Shares Outstanding	7.83	7.83	7.26	-	-
Free Cash Flow	-3.73	-1.35	2.99	1.54	5.8
Free Cash Flow Growth	-	-	94.25%	-73.44%	145.69%
Free Cash Flow Per Share	-0.48	-0.17	0.41	0.23	0.86
Gross Margin	29.22%	40.43%	34.23%	32.30%	30.64%
Operating Margin	2.94%	15.48%	14.47%	11.10%	12.67%
Profit Margin	6.68%	14.55%	14.52%	14.10%	12.67%
FCF Margin	-18.01%	-5.75%	15.10%	8.03%	27.93%
EBITDA	0.85	3.88	3.09	2.49	2.98
EBITDA Margin	4.12%	16.49%	15.61%	12.99%	14.34%
EBIT	0.61	3.64	2.87	2.13	2.63
EBIT Margin	2.94%	15.48%	14.47%	11.10%	12.67%
Effective Tax Rate	-13.45%	-18.26%	-10.67%	1.32%	8.63%

Updated Feb 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q